Margot J. Pont

1.1k citations

27 papers · 798 indexed · h-index 13

Co-authors: Stanley R. Riddell Alexander I. Salter Damian J. Green Andrew J. Cowan Brent L. Wood Qian Wu Gabriel O. Cole Jenna Voutsinas
Topics: CAR-T cell therapy research (21 papers)Immunotherapy and Immune Responses (10 papers)T-cell and B-cell Immunology (10 papers)
Cited by: Hematology Oncology Immunology
Journals: Blood PLoS ONE The Lancet Oncology
Partner nations: United States Netherlands Belgium

In The Last Decade

Margot J. Pont

27 papers receiving 787 citations

Peers

Countries citing papers authored by Margot J. Pont

Since Specialization

Citations

This map shows the geographic impact of Margot J. Pont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margot J. Pont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margot J. Pont more than expected).

Fields of papers citing papers by Margot J. Pont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margot J. Pont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margot J. Pont. The network helps show where Margot J. Pont may publish in the future.

Co-authorship network of co-authors of Margot J. Pont

This figure shows the co-authorship network connecting the top 25 collaborators of Margot J. Pont. A scholar is included among the top collaborators of Margot J. Pont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margot J. Pont. Margot J. Pont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Euplagia-1: A Phase 1/2 Trial of GLPG5201, a Fresh Stem-like Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, in Patients with Relapsed/Refractory CLL and RT 2024 ·Blood ·(unknown),Núria Martínez‐Cibrián,(unknown),(unknown),(unknown),Sandra Blum,(unknown),Marte C. Liefaard,Margot J. Pont,(unknown),Kirsten Van Hoorde,(unknown),Julio Delgado,Natalia Tovar	1
2	Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma 2024 ·Blood ·Marie José Kersten,(unknown),Évelyne Willems,Marte C. Liefaard,Stavros Milatos,Margot J. Pont,(unknown),Eva Santermans,(unknown),Jeevan K. Shetty,Esmée P. Hoefsmit,Omotayo Fasan,Maria T. Kuipers,Sébastien Anguille,Joost S.P. Vermaat	1
3	Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy 2024 ·Blood ·David G. Coffey,Pınar Ataca Atilla,Erden Atilla,Ola Landgren,(unknown),Sylvain Simon,Margot J. Pont,Melissa L. Comstock,Geoffrey R. Hill,Stanley R. Riddell,Damian J. Green	6
4	γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial 2023 ·The Lancet Oncology ·Andrew J. Cowan,Margot J. Pont,Blythe Sather,Cameron J. Turtle,Brian G. Till,Edward N. Libby,David G. Coffey,Sherilyn A. Tuazon,Brent L. Wood,Ted Gooley,(unknown),Jenna Voutsinas,Xiaoling Song,Mazyar Shadman,Jordan Gauthier,Aude G. Chapuis,Filippo Milano,David G. Maloney,Stanley R. Riddell,Damian J. Green	52
5	Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma 2023 ·Blood Advances ·Andrew J. Portuguese,Min Fang,Sherilyn A. Tuazon,Margot J. Pont,Xiaoyu Qu,(unknown),(unknown),(unknown),Gabriel O. Cole,Evan W. Newell,(unknown),Lorinda Soma,Damian J. Green	5
6	Impact of Gamma-Secretase Inhibition on the Multiple Myeloma Immune Microenvironment 2023 ·Blood ·David G. Coffey,Ola Landgren,Andrew J. Cowan,Pınar Ataca Atilla,Sylvain Simon,Margot J. Pont,Melissa L. Comstock,Geoffrey R. Hill,Stanley R. Riddell,Damian J. Green	1
7	Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma 2022 ·Transplantation and Cellular Therapy ·Srirama Josyula,Margot J. Pont,Sayan Dasgupta,Xiaoling Song,Sushma Thomas,Gregory Pepper,(unknown),Terry Stevens‐Ayers,Hans D. Ochs,Michael Boeckh,Stanley R. Riddell,Andrew J. Cowan,Elizabeth M. Krantz,Damian J. Green,Joshua A. Hill	34
8	NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness 2022 ·Blood ·Alec B. Wilkens,(unknown),Margot J. Pont,Gabriel O. Cole,Isabel Leung,(unknown),Matthew R. Hart,Irwin D. Bernstein,Scott N. Furlan,Stanley R. Riddell	15
9	Infectious Complications and Humoral Immunity after BCMA-Directed Chimeric Antigen Receptor T-Cell Therapy in Adults with Multiple Myeloma 2021 ·Transplantation and Cellular Therapy ·Srirama Josyula,Margot J. Pont,(unknown),Xiaoling Song,Sushma Thomas,Gregory Pepper,Elizabeth M. Krantz,Stanley R. Riddell,Andrew J. Cowan,Damian J. Green,Joshua A. Hill	2
10	Safety and Efficacy of Fully Human BCMA CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase BCMA Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma 2021 ·Blood ·Andrew J. Cowan,Margot J. Pont,Blythe Sather,Cameron J. Turtle,Brian G. Till,Edward N. Libby,David G. Coffey,Sherilyn A. Tuazon,Brent L. Wood,Ted Gooley,Qian Wu,Mazyar Shadman,Jordan Gauthier,Aude G. Chapuis,Filippo Milano,David G. Maloney,Stanley R. Riddell,Damian J. Green	16
11	Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens 2020 ·Frontiers in Immunology ·(unknown),M. Willy Honders,Edith D. van der Meijden,(unknown),(unknown),Margot J. Pont,Ramin Monajemi,Szymon M. Kiełbasa,Peter A.C. ’t Hoen,Cornelis A.M. van Bergen,J.H. Frederik Falkenburg,Marieke Griffioen	8
12	TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4+ T Cells to Treg 2020 ·Cell Reports ·Joseph S. Dolina,(unknown),(unknown),Lara Labarta-Bajo,(unknown),Jason Greenbaum,Nawal Bahia El Idrissi,Margot J. Pont,Michael Croft,Stephen P. Schoenberger	10
13	T Cells Specific for an Unconventional Natural Antigen Fail to Recognize Leukemic Cells 2019 ·Cancer Immunology Research ·Margot J. Pont,Rimke Oostvogels,Cornelis A.M. van Bergen,Edith D. van der Meijden,(unknown),(unknown),Marlieke L.M. Jongsma,Henk M. Lokhorst,J.H. Frederik Falkenburg,Tuna Mutis,Marieke Griffioen,Robbert M. Spaapen	8
14	γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma 2019 ·Blood ·Margot J. Pont,Tyler Hill,Gabriel O. Cole,(unknown),Jessica L. Kelliher,Alexander I. Salter,Michael Hudecek,Melissa L. Comstock,Anusha Rajan,Bharvin K.R. Patel,Jenna Voutsinas,Qian Wu,Lingfeng Liu,Andrew J. Cowan,Brent L. Wood,Damian J. Green,Stanley R. Riddell	238
15	Response to Bcma CAR-T Cells Correlates with Pretreatment Target Antigen Density and Is Improved By Small Molecule Inhibition of Gamma Secretase 2019 ·Blood ·Damian J. Green,Margot J. Pont,Andrew J. Cowan,Gabriel O. Cole,Blythe Sather,(unknown),(unknown),Sushma Thomas,Brent L. Wood,Michelle Blake,Melissa Works,Ted Gooley,David G. Maloney,Stanley R. Riddell	22
16	Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2 2016 ·Clinical Cancer Research ·Margot J. Pont,(unknown),Edith D. van der Meijden,Cornelis A.M. van Bergen,Michel G.D. Kester,(unknown),Martijn Vermaat,(unknown),Erik W.A. Marijt,Szymon M. Kiełbasa,Peter A.C. ’t Hoen,J.H. Frederik Falkenburg,Marieke Griffioen	13
17	Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies 2016 ·PLoS ONE ·Margot J. Pont,M. Willy Honders,Anita N. Kremer,Cees van Kooten,Coby Out,Pieter S. Hiemstra,Hetty C. de Boer,MJ JAGER,Eva Schmelzer,Robert G. Vries,Adil S. A. Al Hinai,Wilma G. M. Kroes,Ramin Monajemi,Jelle J. Goeman,Stefan Böhringer,Erik W.A. Marijt,J.H. Frederik Falkenburg,Marieke Griffioen	13
18	The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants 2016 ·PLoS ONE ·(unknown),Margot J. Pont,J.H. Frederik Falkenburg,Marieke Griffioen	5
19	Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte–Derived HLA-Ligandome Using a Reverse Immunology Approach 2015 ·Clinical Cancer Research ·Pleun Hombrink,Cesare Hassan,Michel G.D. Kester,Lorenz Jahn,Margot J. Pont,Arnoud H. de Ru,Cornelis A.M. van Bergen,Marieke Griffioen,J.H. Frederik Falkenburg,Peter A. van Veelen,Mirjam H.M. Heemskerk	18
20	Human Leukocyte Antigen–DO Regulates Surface Presentation of Human Leukocyte Antigen Class II–Restricted Antigens on B Cell Malignancies 2014 ·Biology of Blood and Marrow Transplantation ·Anita N. Kremer,Edith D. van der Meijden,M. Willy Honders,Margot J. Pont,Jelle J. Goeman,J.H. Frederik Falkenburg,Marieke Griffioen	9

About Margot J. Pont

Margot J. Pont is a scholar working on Hematology, Immunology and Oncology, having authored 27 papers that have together received 798 indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (10 papers). The work is most often cited by research in Hematology (251 citations), Oncology (600 citations) and Immunology (235 citations). Margot J. Pont has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Stanley R. Riddell, Alexander I. Salter, Damian J. Green, Andrew J. Cowan, Brent L. Wood, Qian Wu, Gabriel O. Cole, Jenna Voutsinas, Melissa L. Comstock and Lingfeng Liu. Their work appears in journals such as Blood, PLoS ONE and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact